Interactive AI-based Mental Health Service for the Patients With Cancer
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · May 10, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mental health service designed specifically for patients with cancer, using interactive artificial intelligence (AI). The goal is to better understand the mental health needs of cancer patients and to develop tailored support that can help them during their treatment journey. Researchers will gather information from surveys and interviews with patients to create new ways to assess and support their mental health.
To be eligible for this trial, participants must be adults who have been diagnosed with a type of cancer and are currently receiving treatment or are in follow-up care after finishing their treatment. However, patients who cannot give consent or participate in interviews due to cognitive difficulties will not be included. Those who join the trial can expect to share their experiences and thoughts, which will help shape future mental health services for cancer patients. This study is currently recruiting participants of all genders, and it aims to provide valuable insights into improving mental health care in this important area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with malignant tumor and undergoing treatment, or patients undergoing follow-up after completing curative treatment
- Exclusion Criteria:
- • Patients unable to consent to research or be interviewed due to cognitive decline
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Bong-jin Hahm, M.D., Ph.D.
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported